Skip to main content

is part of the Informa Markets Division of Informa PLC

  • INFORMA PLC
  • ABOUT US
  • INVESTOR RELATIONS
  • TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Eurogin
 
  • 
  • Scientific Information
    • Message from the Chairman of the Scientific Committee
    • Program Committee
    • Program Objectives
    • Key Features And Target Audience
    • Previous Congress Presidents
    • Previous Congresses
  • Program & CME
    • Online Program
    • Program Download
    • Program Overview
    • Program Topics
    • EUROGIN Pre-Congress Webinars
    • CME Credits
    • Cervical Cancer Screening Organization around the world
    • Vulvovaginal & Anal Diseases
    • HPV And Head & Neck Forum
    • List of Posters
  • Registration
    • Registration Information
  • Abstracts & Posters
    • Abstract Topics
    • ABSTRACTS EUROGIN 2021
  • Sponsorship And Exhibition
    • Sponsorship Information
    • Sponsorship Brochure 2021
    • Sponsors and Exhibitors
    • Satellite Symposia
    • Ethical Compliance
  • Congress Information
    • Contact us
    • newsletter
    • Legal Information
    • Picture Gallery 2019
Previous
Next

I attended EUROGIN 2021

Watch the VOD and claim your certificate of attendance & CME credits

MORE INFORMATION
img-responsive

Workshop Francophone France's flag

ACCÉDER À LA VOD
img-responsive

EUROGIN PRE-CONGRESS WEBINAR SERIES

HIGHLIGHTS ON HPV INFECTION & ASSOCIATED CANCER
FROM RESEARCH TO PRACTICE

MORE INFORMATION
img-responsive
REPLAY OUR PAST WEBINARs
On-demand Webinars

Host-cell DNA Methylation Markers for Anogenital Cancer

Daniëlle Heideman - Renske Steenbergen

Disruption of DNA methylation patterns is one of the hallmarks of cancer, including high-risk human papillomavirus (hrHPV)-driven anogenital cancers. Several hyper-methylated cellular genes have been found associated with carcinogenesis of the uterine cervix or other anogenital sites. This finding is now increasingly being used as morphology-independent biomarker for the management of hrHPV-positive women in cervical screening, or for risk stratification of patients diagnosed with premalignant anogenital disease (CIN, VIN, AIN). The webinar will highlight research on altered DNA methylation in hrHPV-induced carcinogenesis, and the potential clinical applications thereof.
▶ Replay

Updates in HPV-positive Head and Neck Cancers

Eleni Rettig

Overview of recent developments in epidemiology, management, and biomarkers of HPV-positive head and neck cancers.
▶ Replay

HPV Vaccine Immune Responses by Age and Gender

Joakim Dillner

Vaccination strategies used will greatly affect the progress towards elimination. I will discuss effectiveness and immunity depending on age groups and genders to be targeted.
▶ Replay

Cervical cancer prevention: HPV Vaccine Impact and Safety

Julia Brotherton

This webinar will provide a brief primer on the mountain of evidence now supporting both the safety and impact of HPV vaccines in population use, as an introduction to the latest data which will be presented at Eurogin 2021.
▶ Replay

Risk Adapted Triage for Cervical Screening

Jack Cuzick

There are no clear factors for deciding who to screen for cervix cancer, other than previous abnormalities and the results of an initial test. The initial test can be either cytology or HPV testing. As we are moving towards primary HPV testing the focus here will be on the risk of disease based on a primary HPV test, how this can be refined by doing different triage tests. These include HPV genotyping, cytology, methylation, and p16 in a liquid-based sample. Algorithms for how best to employ these (depending on what is routinely available) will be discussed.
▶ Replay

Sponsorship

For sponsorship and exhibition enquiries, please contact Peter Mattonet: [email protected]

Sponsors & Exhibitors List

SEE THE 2021 EXHIBITORS LIST
img-responsive
EXHIBITING OPPORTUNITIES
img-responsive

Ethical Med Tech

The EUROGIN congress has been vetted as COMPLIANT by the Ethical Med Tech conferene vetting system on all assessment criteria:

  • Scientific Programme
  • Geographic Location
  • Conference Venue
  • Hospitality
  • Registration Packages
  • Communication

PHOTO GALLERY2019

OPENING CEREMONY

SCIENTIFIC SESSIONS

REGISTRATION

EXHIBITION

ABOUT EUROGIN

EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) brings together clinicians and scientists whose work is related to genital infections and neoplasia.

ETHICAL COMPLIANCE

TRUSTED PARTNER

 

 

USEFUL LINKS

  • EUROGIN PORTAL |
  • EUROGIN FRANCE |
  • Previous events |
  • Legal Information |
  • Cancellation Policy |
  • Delegates Terms & Conditions |
  • Refund Request Process

RELATED EVENTS / PARTNERSHIPS

Informa Markets

Copyright © 2021. All rights reserved. Informa Markets, a trading division of Informa PLC.

  • Accessibility|
  • Privacy Policy |
  • Cookie Policy|
  • Terms of Use|
  • Visitor Terms And Conditions